Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arepanrix H1N1 Vaccine in HIV-Infected Adults
NCT01002040Phase 4Completed
- Sponsor
- University of British Columbia
- Start
- Feb 2010
- Primary completion
- Jul 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in influenza, sponsored by University of British Columbia. Started Feb 2010; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01002040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002040.